4 weeks TG Therapeutics (NASDAQ:TGTX) Now Covered by TD CowenMarketBeat
TD Cowen initiated coverage on shares of TG Therapeutics in a research report on Tuesday. They issued a “buy” rating and a $50.00 price objective for the company.
XTD Cowen initiated coverage on shares of TG Therapeutics in a research report on Tuesday. They issued a “buy” rating and a $50.00 price objective for the company.
X